<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1688-0390</journal-id>
<journal-title><![CDATA[Revista Médica del Uruguay]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. Méd. Urug.]]></abbrev-journal-title>
<issn>1688-0390</issn>
<publisher>
<publisher-name><![CDATA[Sindicato Médico del Uruguay]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1688-03902026000101501</article-id>
<article-id pub-id-type="doi">10.29193/rmu.42.1.10</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Pronóstico de la hemorragia subaracnoidea aneurismática en Uruguay: 3 años de seguimiento evolutivo en cohorte de 211 pacientes]]></article-title>
<article-title xml:lang="en"><![CDATA[Prognosis of aneurysmal subarachnoid hemorrhage in Uruguay: 3 years of evolutionary follow-up in a cohort of 211 patients]]></article-title>
<article-title xml:lang="pt"><![CDATA[Prognóstico da hemorragia subaracnoide aneurismática no Uruguai: 3 anos de seguimento evolutivo em uma coorte de 211 pacientes]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jaume]]></surname>
<given-names><![CDATA[Alejandra]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pereira]]></surname>
<given-names><![CDATA[Lucía]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Negrotto]]></surname>
<given-names><![CDATA[Matías]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Romero]]></surname>
<given-names><![CDATA[Mariana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Macadam]]></surname>
<given-names><![CDATA[J. Pedro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Martínez]]></surname>
<given-names><![CDATA[Fernando]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Gil]]></surname>
<given-names><![CDATA[Juan]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Administración de los Servicios de Salud del Estado Servicio de Neurocirugía Hospital Maciel]]></institution>
<addr-line><![CDATA[Montevideo ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad de la República Facultad de Medicina Cátedra de Imagenología, Hospital de Clínicas]]></institution>
<addr-line><![CDATA[Montevideo ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad de la República Facultad de Medicina Cátedra de Neurocirugía, Hospital de Clínicas]]></institution>
<addr-line><![CDATA[Montevideo ]]></addr-line>
<country>Uruguay</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad de la República Facultad de Medicina Unidad Académica de Métodos Cuantitativos]]></institution>
<addr-line><![CDATA[Montevideo ]]></addr-line>
<country>Uruguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2026</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2026</year>
</pub-date>
<volume>42</volume>
<numero>1</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_arttext&amp;pid=S1688-03902026000101501&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_abstract&amp;pid=S1688-03902026000101501&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.edu.uy/scielo.php?script=sci_pdf&amp;pid=S1688-03902026000101501&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción: la hemorragia subaracnoidea aneurismática (HSAa) representa una de las patologías cerebrovasculares de mayor mortalidad y discapacidad. En Uruguay, hasta hace pocos años no existían datos epidemiológicos nacionales sobre el pronóstico a largo plazo.  Materiales y métodos: se realizó un estudio prospectivo, multicéntrico y nacional que incluyó 211 pacientes adultos diagnosticados con HSAa entre noviembre de 2019 y octubre de 2020. Se recopilaron variables clínicas, imagenológicas, terapéuticas y sociales. El seguimiento se extendió a 3 años, evaluando la evolución funcional mediante la escala de Rankin modificada (mRS). Se identificaron factores pronósticos mediante modelos de riesgos proporcionales de Cox.  Resultados: la mortalidad global a 3 años fue del 54,5%, sin variaciones respecto a los 6 meses. La proporción de pacientes con buena evolución (mRS 0&#8211;2) aumentó progresivamente: 30% al alta, 35,5% a los 6 meses y 38% a los 3 años. Entre los sobrevivientes, el 68% no presentó secuelas neurocognitivas. En el análisis multivariado, la edad &gt; 65 años (OR: 2,3; IC: 1,0-5,5), HSA grave al inicio (WFNS 4&#8211;5) (RR: 2,8; IC95%: 1,2&#8211;6,7) y la falta de acceso a rehabilitación (RR: 2,5; IC95%: 1,6&#8211;3,8) fueron predictores independientes de mala evolución clínica a largo plazo.  Conclusiones: este es el primer estudio nacional que reporta el pronóstico a 3 años de la HSAa en Uruguay. La edad mayor a 65 años, la gravedad clínica inicial y la ausencia de acceso a rehabilitación se consolidan como factores determinantes en la evolución funcional, lo que subraya la necesidad de un abordaje terapéutico agresivo en casos graves y de políticas de salud orientadas a la creación de centros de neurorehabilitación especializados.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction: aneurysmal subarachnoid hemorrhage (aSAH) is one of the cerebrovascular diseases with the highest mortality and disability rates. In Uruguay, epidemiological data on long-term prognosis were lacking until recently.  Materials and methods: a prospective, multicenter, nationwide study was conducted including 211 adult patients diagnosed with aSAH between November 2019 and October 2020. Clinical, imaging, therapeutic, and social variables were collected. Patients were followed for 3 years, with functional outcome assessed using the modified Rankin Scale (mRS). Prognostic factors were identified through Cox proportional hazards models.  Results: overall mortality at 3 years was 54.5%, unchanged from the 6-month follow-up. The proportion of patients with favorable outcomes (mRS 0&#8211;2) progressively increased: 30% at discharge, 35.5% at 6 months, and 38% at 3 years. Among survivors, 68% had no neurocognitive sequelae. In multivariate analysis, age &gt;65 years (OR: 2.3; CI: 1.0&#8211;5.5), poor-grade aSAH at admission (WFNS 4&#8211;5) (RR: 2.8; 95%CI: 1.2&#8211;6.7) and lack of access to rehabilitation (RR: 2.5; 95%CI: 1.6&#8211;3.8) were independent predictors of poor functional outcome.  Conclusions: this is the first nationwide study reporting 3-year outcomes of aSAH in Uruguay. Age over 65, initial clinical severity and lack of access to rehabilitation emerged as key determinants of long-term prognosis, highlighting the need for aggressive management in severe cases and the development of specialized neuro-rehabilitation centers in the country.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Introdução: a hemorragia subaracnóidea aneurismática (HSaa) está entre as doenças cerebrovasculares de maior mortalidade e incapacidade. No Uruguai, até poucos anos atrás, não existiam dados epidemiológicos nacionais sobre o prognóstico a longo prazo.  Materiais e métodos: realizou-se um estudo prospectivo, multicêntrico e nacional que incluiu 211 pacientes adultos diagnosticados com HSaa entre novembro de 2019 e outubro de 2020. Foram coletadas variáveis clínicas, de imagem, terapêuticas e sociais. O seguimento foi estendido a 3 anos, avaliando a evolução funcional pela escala de Rankin modificada (mRS). Fatores prognósticos foram identificados por modelos de riscos proporcionais de Cox.  Resultados: a mortalidade global em 3 anos foi de 54,5%, sem variação em relação aos 6 meses. A proporção de pacientes com boa evolução (mRS 0&#8211;2) aumentou progressivamente: 30% na alta, 35,5% aos 6 meses e 38% aos 3 anos. Entre os sobreviventes, 68% não apresentaram sequelas neurocognitivas. Na análise multivariada, idade &gt; 65 anos (OR: 2,3; IC: 1,0&#8211;5,5), HSaa grave no início (WFNS 4&#8211;5) (RR: 2,8; IC95%: 1,2&#8211;6,7) e falta de acesso à reabilitação (RR: 2,5; IC95%: 1,6&#8211;3,8) foram preditores independentes de pior evolução clínica a longo prazo.  Conclusões: este é o primeiro estudo nacional que relata o prognóstico em 3 anos da HSaa no Uruguai. Idade superior a 65 anos, gravidade clínica inicial e ausência de acesso à reabilitação consolidam-se como fatores determinantes na evolução funcional, reforçando a necessidade de manejo agressivo nos casos graves e de políticas de saúde voltadas para o desenvolvimento de centros especializados de neurorreabilitação.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Hemorragia subaracnoideo]]></kwd>
<kwd lng="es"><![CDATA[Aneurisma]]></kwd>
<kwd lng="es"><![CDATA[Pronóstico]]></kwd>
<kwd lng="es"><![CDATA[Rehabilitación]]></kwd>
<kwd lng="es"><![CDATA[Uruguay]]></kwd>
<kwd lng="en"><![CDATA[Subarachnoid hemorrhage]]></kwd>
<kwd lng="en"><![CDATA[Aneurysm]]></kwd>
<kwd lng="en"><![CDATA[Prognosis]]></kwd>
<kwd lng="en"><![CDATA[Rehabilitation]]></kwd>
<kwd lng="en"><![CDATA[Uruguay]]></kwd>
<kwd lng="pt"><![CDATA[Hemorragia subaracnoide aneurismática]]></kwd>
<kwd lng="pt"><![CDATA[Aneurisma]]></kwd>
<kwd lng="pt"><![CDATA[Prognóstico]]></kwd>
<kwd lng="pt"><![CDATA[Reabilitação]]></kwd>
<kwd lng="pt"><![CDATA[Uruguai]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1.</label><nlm-citation citation-type="book">
<collab>Comisión Honoraria para la Salud Cardiovascular</collab>
<article-title xml:lang=""><![CDATA[Área de Epidemiología y Estadística. Uruguay]]></article-title>
<source><![CDATA[Mortalidad por enfermedades cardiovasculares en el Uruguay 2020]]></source>
<year>2020</year>
<publisher-loc><![CDATA[Montevideo ]]></publisher-loc>
<publisher-name><![CDATA[CHSC]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Choi]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[HS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The incidence and characteristics of patients with small ruptured aneurysms (&lt;5 mm) in subarachnoid hemorrhage]]></article-title>
<source><![CDATA[J Korean Neurosurg Soc]]></source>
<year>2017</year>
<volume>60</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>424-32</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jaume]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Gil]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Negrotto]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Macadam]]></surname>
<given-names><![CDATA[JP]]></given-names>
</name>
<name>
<surname><![CDATA[De los Santos]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Pereira]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prognostic factors in patients with aneurysmal subarachnoid hemorrhage in Uruguay: presentation of a multi-center prospective study]]></article-title>
<source><![CDATA[J Brain Neurol Disord]]></source>
<year>2023</year>
<volume>7</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B4">
<label>4.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arikan]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Errando]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Lagares]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Variability of clinical and angiographic results based on the treatment preference (endovascular or surgical) of centers participating in the subarachnoid hemorrhage database of the Working Group of the Spanish Society of Neurosurgery]]></article-title>
<source><![CDATA[World Neurosurg]]></source>
<year>2020</year>
<volume>135</volume>
<page-range>e339-49</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lagares]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Munarriz]]></surname>
<given-names><![CDATA[PM]]></given-names>
</name>
<name>
<surname><![CDATA[Ibáñez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Variabilidad en el manejo de la hemorragia subaracnoidea aneurismática en España: análisis de la base de datos prospectiva multicéntrica del Grupo de Enfermedades Neurovasculares de la Sociedad Española de Neurocirugía]]></article-title>
<source><![CDATA[Neurocirugía (Astur)]]></source>
<year>2015</year>
<volume>26</volume>
<page-range>167-79</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ironside]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Buell]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Kumar]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Paisan]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Sokolowski]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[High-grade aneurysmal subarachnoid hemorrhage: predictors of functional outcome]]></article-title>
<source><![CDATA[World Neurosurg]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B7">
<label>7.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mocco]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Ransom]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Komotar]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Schmidt]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sciacca]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Mayer]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Preoperative prediction of long-term outcome in poor-grade aneurysmal subarachnoid hemorrhage]]></article-title>
<source><![CDATA[Neurosurgery]]></source>
<year>2006</year>
<volume>59</volume>
<page-range>529-38</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rosen]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Macdonald]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Grading of subarachnoid hemorrhage: modification of the World Federation of Neurosurgical Societies scale on the basis of data for a large series of patients]]></article-title>
<source><![CDATA[Neurosurgery]]></source>
<year>2004</year>
<volume>54</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>566-76</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hoh]]></surname>
<given-names><![CDATA[BL]]></given-names>
</name>
<name>
<surname><![CDATA[Ko]]></surname>
<given-names><![CDATA[NU]]></given-names>
</name>
<name>
<surname><![CDATA[Amin-Hanjani]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Chou]]></surname>
<given-names><![CDATA[SHY]]></given-names>
</name>
<name>
<surname><![CDATA[Cruz-Flores]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Dangayach]]></surname>
<given-names><![CDATA[NS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[2023 Guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association/American Stroke Association]]></article-title>
<source><![CDATA[Stroke]]></source>
<year>2023</year>
<volume>54</volume>
<page-range>314-70</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van Donkelaar]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bakker]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Birks]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Veeger]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Metzemaekers]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Molyneux]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Prediction of outcome after aneurysmal subarachnoid hemorrhage: development and validation of the SAFIRE grading scale]]></article-title>
<source><![CDATA[Stroke]]></source>
<year>2019</year>
<volume>50</volume>
<page-range>00</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11.</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[AlMatter]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Aguilar Pérez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bhogal]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Hellstern]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Ganslandt]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Henkes]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[Results of interdisciplinary management of 693 patients with aneurysmal subarachnoid hemorrhage: clinical outcome and relevant prognostic factors]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B12">
<label>12.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jabbarli]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Reinhard]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Roelz]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Shah]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Niesen]]></surname>
<given-names><![CDATA[WD]]></given-names>
</name>
<name>
<surname><![CDATA[Kaier]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The predictors and clinical impact of intraventricular hemorrhage in patients with aneurysmal subarachnoid hemorrhage]]></article-title>
<source><![CDATA[Int J Stroke]]></source>
<year>2016</year>
<volume>11</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>68-76</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ohbuchi]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Hagiwara]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Arai]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Yoneyama]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Takahashi]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Inazuka]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Optimal timing and safety of external ventricular drainage in patients with high-grade aneurysmal subarachnoid hemorrhage treated with endovascular coiling]]></article-title>
<source><![CDATA[J Clin Neurosci]]></source>
<year>2021</year>
<volume>88</volume>
<page-range>95-100</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14.</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Claassen]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Spontaneous subarachnoid haemorrhage]]></article-title>
<source><![CDATA[Lancet]]></source>
<year>2022</year>
<volume>400</volume>
<numero>10355</numero>
<issue>10355</issue>
<page-range>846-62</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
